Pharma Journalist -

Concert Pharmaceuticals announced that it has completed patient enrollment of an open label clinical trial to evaluate once-daily 24 mg compared to twice-daily 12 mg oral dosing of…
Read More...

Novartis, a leader reimagining rheumatology and immuno-dermatology, announced positive new data from the PREVENT trial evaluating the efficacy and safety of Cosentyx (secukinumab) in…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted…
Read More...

Merck, known as MSD outside the United States and Canada, and Eisai announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s anti-PD-1…
Read More...

SMi Reports: Exclusive interview with industry expert from Novartis, 3 weeks ahead of the inaugural Wearable Injectors and Connected Devices conference 2019 The Wearable Injectors…
Read More...

AlivaMab Discovery Services, a company providing custom human therapeutic antibody drug discovery services using the AlivaMab Mouse, a best-in-class antibody discovery platform,…
Read More...

Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which…
Read More...

Alnylam Pharmaceuticals announced that the Company has initiated APOLLO-B, a global Phase 3 placebo-controlled clinical trial of patisiran, an intravenously administered RNAi…
Read More...

Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems,…
Read More...

H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals announced a definitive agreement for Lundbeck to acquire Alder. Under the terms of the agreement, Lundbeck will commence a tender…
Read More...